Auricular acupressure as a complementary therapy for psoriasis vulgaris: study protocol for a multicenter randomized controlled trial
- PMID: 31208470
- PMCID: PMC6580514
- DOI: 10.1186/s13063-019-3475-4
Auricular acupressure as a complementary therapy for psoriasis vulgaris: study protocol for a multicenter randomized controlled trial
Abstract
Introduction: Psoriasis vulgaris is a common skin disease characterized by persistent localized erythematous scaly plaques, typically on the elbows, knees, and scalp. It is an immune-abnormal disease that progresses slowly over a long period with frequent symptom recurrence. Current studies have shown that acupuncture is an effective therapy for psoriasis. However, the scientific evidence of the efficacy of auricular acupressure treatment for patients with psoriasis is still insufficient. Therefore, we designed a randomized controlled clinical trial to investigate the effect, safety, and cost-effectiveness of auricular acupressure in addition to medication in patients with psoriasis.
Methods and analysis: This on-going study is a two-arm parallel, assessor-blinded, randomized controlled trial in which 180 participants with psoriasis will be recruited and then randomly allocated into two groups in a 1:1 ratio. Equal randomization will be conducted using a computer-generated random allocation sequence. Participants in the intervention group will receive auricular acupressure treatment once per week for 4 weeks, and calcipotriol betamethasone ointment for topical use once daily for 4 weeks. Participants in the control group will receive only calcipotriol betamethasone ointment treatment once daily for 4 weeks. All patients will be followed up for 12 weeks. The primary outcome is relapse rate. The secondary outcomes include time to relapse, rebound rate, time to new onset, Psoriasis Area and Severity Index score improvement rate, body surface area affected, a visual analogue scale, and Dermatology Life Quality Index. Cost-effectiveness analysis will be carried out from a health and community care provider perspective.
Discussion: This multicenter randomized controlled trial will provide important clinical evidence for the effect and safety of auricular acupressure as a complementary therapy in patients with psoriasis.
Trial registration: Chinese Clinical Trial Registry, ChiCTR-TRC-14004916 . Registered on 20 May 2014. This protocol is version 3.0 which was updated on 24 September 2016.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized controlled trial.Trials. 2014 Jul 22;15:294. doi: 10.1186/1745-6215-15-294. Trials. 2014. PMID: 25052161 Free PMC article. Clinical Trial.
-
A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.Trials. 2016 Oct 3;17(1):482. doi: 10.1186/s13063-016-1610-z. Trials. 2016. PMID: 27716422 Free PMC article. Clinical Trial.
-
Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial.Trials. 2021 Feb 25;22(1):162. doi: 10.1186/s13063-021-05138-3. Trials. 2021. PMID: 33632286 Free PMC article.
-
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.Drugs. 2011 Apr 16;71(6):709-30. doi: 10.2165/11207300-000000000-00000. Drugs. 2011. PMID: 21504248 Review.
-
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967117 Review.
Cited by
-
Interferon Point Alteration in Hospitalized Patients with and Without COVID-19.Med Acupunct. 2024 Dec 17;36(6):343-349. doi: 10.1089/acu.2023.0095. eCollection 2024 Dec. Med Acupunct. 2024. PMID: 39712526
-
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models.Mol Diagn Ther. 2025 May;29(3):345-366. doi: 10.1007/s40291-025-00776-8. Epub 2025 Apr 1. Mol Diagn Ther. 2025. PMID: 40167939 Review.
-
Auricular Acupressure Effect on Autonomic Responses Evoked by a Cold Pressor Test in Healthy Volunteers: A Pilot Study.Evid Based Complement Alternat Med. 2022 Dec 13;2022:5703760. doi: 10.1155/2022/5703760. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36561603 Free PMC article.
-
Mind-Body Interventions as Alternative and Complementary Therapies for Psoriasis: A Systematic Review of the English Literature.Medicina (Kaunas). 2021 Apr 23;57(5):410. doi: 10.3390/medicina57050410. Medicina (Kaunas). 2021. PMID: 33922733 Free PMC article.
References
-
- Lu CJ, Yu JJ, Deng JW. Disease-syndrome combination clinical study of psoriasis: present status, advantages, and prospects. Chin J Integr Med. 2012;18(3):166–171. - PubMed
-
- Velez NF, Wei-Passanese EX, Husni ME, Mody EA, Qureshi AA. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res. 2012;304(1):7–13. - PubMed
-
- Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–850. - PubMed
-
- Xiwen L. Huangdi Neijing. China Press of Traditional Chinese Medicine. 2009. p. p68.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases